Elkfork Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Elkfork Partners’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$217K	Buy	26,146 +714	+3%	+$5.78K	0.01%	806
2019 Q2	$219K	Buy	25,432 +3,366	+15%	+$30.1K	0.01%	804
2019 Q1	$236K	Hold	22,066	–	–	0.01%	766
2018 Q4	$193K	Buy	22,066 +3,706	+20%	+$47.2K	0.01%	781
2018 Q3	$309K	Buy	18,360 +1,598	+10%	+$34.6K	0.01%	735
2018 Q2	$351K	Hold	16,762	–	–	0.01%	628
2018 Q1	$270K	Buy	16,762 +1,700	+11%	+$33.7K	0.01%	706
2017 Q4	$285K	Buy	15,062 +7,922	+111%	+$143K	0.01%	688
2017 Q3	$101K	Buy	+7,140	New	+$64.6K	﹤0.01%	896

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elkfork Partners's SPPI Position: Q3 2019 in Review

Elkfork Partners increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 2.8% in Q3 2019, buying an estimated $5.78K and bringing the position to 26,146 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #806.

Elkfork Partners first reported a position in SPPI in Q3 2017 and has held it in 9 quarters since. The position peaked at $351K in Q2 2018. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Elkfork Partners held 26,146 shares of Spectrum Pharmaceuticals Inc worth $217K as of Q3 2019.
Elkfork Partners bought 714 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $5.78K.
Spectrum Pharmaceuticals Inc made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #806 holding.
Elkfork Partners first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and has held it in 9 quarters since.
Elkfork Partners's Spectrum Pharmaceuticals Inc position peaked at $351K in Q2 2018.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.